Pure Global
CDSCO UID MFG/IVD/2019/000007_666631a2fcbd1d98fa8539c9e3f522e6_b80e0d1268e845c7247680481d3b9a6c

Fully Automatic Biochemistry Analyzer

Nucleus Diagnosys LLP·Device Class Class A·India CDSCO·Brand: NV4N
Registration details
UID
MFG/IVD/2019/000007_666631a2fcbd1d98fa8539c9e3f522e6_b80e0d1268e845c7247680481d3b9a6c
Device class
Class A
Brand name
NV4N
License holder
Nucleus Diagnosys LLP
Approving authority
Gujarat
Product information
Fully Automatic Biochemistry Analyzer is for in vitro diagnostic use in clinical laboratories and designed for in vitro quantitative determination of clinical chemistries in serum, plasma, urine or cerebrospinal fluid samples. This Fully Automatic Biochemistry Analyzer is more suitable for medium to large laboratories that need to analyze large quantities of samples
Similar products (10)
Other products with the same name or brand
Blood collection tube - clot activator 2. Brand
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood collection Tube - Lithium Heparin
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Electrolyte Analyzer
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood collection Tube - Sodium Heparin
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood Collection Tube - PRP
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood collection tube - Lithium Heparin
Brand: NV4N
Nucleus Diagnosys LLP
Class A
ESR Analyzer
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood collection tube - K2 EDTA
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood collection Tube - Sodium Citrate
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Blood collection Tube - Gel + Lithium Heparin
Brand: NV4N
Nucleus Diagnosys LLP
Class A
Other products from Nucleus Diagnosys LLP
Products from the same license holder (10 products)
Diagnostics test reagent/ kits for RF, ASO and CRP Control
Class C
Covid-19 Rapid Antigen Test-COVID-19 Antigen Test is a rapid and convenient immunochromatographic assay for the qualitative detection of COVID-19 antigen from nasopharyngeal/nasal swab obtained from patient with signs and symptoms of respiratory infection. This test is for administration by healthcare workers and labs only, as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms of SARS-CoV-2 infection. It provides only an initial screening test result. This product is strictly for medical professional use only and not intended for personal use. The result of this test should not be the sole basis for the diagnosis and the test results should be confirmed by Real-Time Reverse Transcriptase
Brand: HIV 1&2
Class D
Diagnostic tests/Reagents/kits for monitoring Phencyclidine drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Barbiturates drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Methaqualone drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Tricycilic Antidepressants drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Propoxyphene drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Methamphetamine drug levels used for therapy or abuse
Class C
Diagnostics test reagent/ kits for Troponin I
Brand: TRA
Class C
Diagnostics Test for Syphilis Rapid Test
Class D
About this record

Fully Automatic Biochemistry Analyzer is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000007_666631a2fcbd1d98fa8539c9e3f522e6_b80e0d1268e845c7247680481d3b9a6c. This device is marketed under the brand name NV4N. The license holder is Nucleus Diagnosys LLP, and it is classified as Device Class Class A. The approving authority is Gujarat.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.